Stefan T Gerner

Neurology — Universitätsklinikum Erlangen, Germany

LeadR Profile

Stefan T Gerner Universitätsklinikum Erlangen Germany
613 ScienceLeadR Reputation 613
Network Map

Neurology

Subspecialties: Cardiology - Hematology - Biochemistry

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 2014 - 2026

Source: PubMed

University of Erlangen-Nuremberg

could not re-read experiences after save", error); return null; } if (persistedEntries === null) { return null; } if (persistedEntries.length === 0 && sent.some((entry) => entry.isvisible !== false)) { console.warn(" re-read after save came back empty, keeping the edited entries"); return null; } this.state.current.experience = persistedEntries; const expected = this.yearsSignature(sent); const received = this.yearsSignature(persistedEntries.map((entry) => ({ isvisible: entry.isvisible, topresent: entry.topresent, year_start: entry.startperiod, year_stop: entry.endperiod }))); if (expected !== received) { console.error(" saved experiences were not persisted as sent", { sent: expected, received: received }); return false; } return true; }, async fetchExperiences() { const response = await $.ajax({ url: ajaxLoadUserData, type: "POST", data: { security: ajaxDataLoadUserData.security, data_to_load: "OrganizationHisto", } }); const parsedData = JSON.parse(response); if (parsedData.loaded === false || !parsedData.user_data || !Array.isArray(parsedData.user_data)) { return null; } return parsedData.user_data.map((value, index) => ({ company: value["name"], url: "", position: (value.hasOwnProperty("position") ? ( value["position"] ) : ( "" ) ), startperiod: value["year_start"], endperiod: value["year_stop"], topresent: (value.hasOwnProperty("topresent") ? ( value["topresent"] ) : ( false ) ), orgid: value["orgid"], isvisible: (value.hasOwnProperty("isvisible") ? ( value["isvisible"] ) : ( true ) ), description: "", tags: [], isOpen: false, ismain: (value.hasOwnProperty("ismain") ? ( value["ismain"] ) : ( (index === 0) ? true : false ) ) })); }, async loadDataOnMount() { this.loading = true; try { const experiences = await this.fetchExperiences(); this.loadFailed = experiences === null; if (experiences !== null) { this.state.current.experience = experiences; } } catch (error) { console.warn(" could not load experiences", error); this.loadFailed = true; } this.loading = false; } }, computed: { experience: { get() { return this.state.current.experience }, }, }, async mounted() { await this.loadDataOnMount() }, } }; })

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 146

Citations

Citations: 4 343 1st author: 14 Last author: 14 Unique author: 0


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Discontinuation of intravenous thrombolysis in acute ischemic stroke.
ischemic stroke, stroke, therapeutics, nervous system diseases
BMC Neurol20260
Successful Treatment of Post-pump Chorea With Tiapride in an Adult Cardiac Surgery Patient: A Case Report.
cardiopulmonary bypass, therapeutics, chorea, movement
Case Rep Crit Care20260
Quality monitoring in telestroke networks: real-world insights from survey response data and literature review.
stroke, hospital mortality
Front Stroke20260
Associations Between Delayed Cerebral Ischemia in Spontaneous Subarachnoid Hemorrhage and Dysfunction of Autonomic Cardiovascular Modulation Compared to Transcranial Doppler Ultrasound Findings.
ultrasonography, doppler, autonomic nervous system, hemorrhage, subarachnoid hemorrhage, ultrasonics, ischemia
Diagnostics (Basel)20260
Parametric color-coding-derived microvascular transit time may predict infarction and reveals microcirculatory benefits of Tenecteplase in acute ischemic stroke.
microcirculation, ischemic stroke, stroke, fibrinolytic agents, tenecteplase, therapeutics
Front Neurol20260

Clinical Studies 15

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

Phase 3 7
N/A 5
Phase 4 2
Phase 2/Phase 3 1

By status:

Completed 8
Recruiting 5
Active not recruiting 2

By type:

Interventional 10
Observational 5

By Monocentric/Multicentric:

monocentric 5
multicentric2to4 0
multicentric5to9 1
multicentricup10 9

Main Topics

Cohort/Consortium Investigators 1

Ongoing Clinical Trials

5 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
A Phase 3 Placebo controlled Study of Milvexian after an Acute Ischemic Stroke or High Risk Transient Ischemic Attack
2022-501176-26-00 — safety, ischemic stroke, stroke, ischemic attack, transient, factor xia, factor xia inhibitor
Phase 3Active not recruiting2023
Thrombolysis with Tenecteplase for Acute Ischemic Stroke in Patients taking Direct Oral Anticoagulants
2025-521762-99-00 — anticoagulants, ischemic stroke, stroke, tenecteplase, direct-acting oral anticoagulants
Phase 3Recruiting2026
Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial Part 2
NCT07227246 — cerebral hemorrhage, hemorrhage, blood, stroke, vaccines, hemorrhagic stroke, blood pressure, factor viia, therapeutics, biological products
Phase 3Recruiting2025
Urin based Point of Care Testing for Direct Oral Anticoagulants in Stroke Patients
NCT06037200 — research design, anticoagulants, stroke, point-of-care systems, hemorrhagic stroke, point-of-care testing, direct-acting oral anticoagulants
N/ARecruiting2023
Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic Stroke
NCT05691244 — safety, saline solution, ischemic stroke, stroke, endothelins, pharmaceutical preparations, receptor, endothelin b, solutions, pharmaceutical vehicles
Phase 3Recruiting2025

LeadR Networks

Main global connection map